Fiduciary Trust International’s AstraZeneca AZN Stock Holding History

Fiduciary Trust International’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-54,200	Closed	-$4.84M	–	136
2020 Q1	$4.84M	Hold	54,200	–	–	0.9%	27
2019 Q4	$5.41M	Sell	54,200 -27,100	-33%	-$2.55M	0.87%	31
2019 Q3	$7.25M	Buy	81,300 +27,100	+50%	+$2.35M	1.49%	19
2019 Q2	$4.47M	Sell	54,200 -27,100	-33%	-$2.12M	1.01%	27
2019 Q1	$5.69M	Sell	81,300 -71	-0.1%	-$5.6K	1.43%	15
2018 Q4	$6.18M	Buy	81,371 +71	+0.1%	+$5.54K	1.89%	13
2018 Q3	$6.43M	Hold	81,300	–	–	1.85%	11
2018 Q2	$5.71M	Hold	81,300	–	–	1.7%	12
2018 Q1	$5.69M	Sell	81,300 -160	-0.2%	-$11.1K	1.42%	15
2017 Q4	$5.65M	Buy	81,460 +160	+0.2%	+$10.8K	1.41%	14
2017 Q3	$5.51M	Buy	+81,300	New	+$5.14M	1.42%	14
2017 Q2	–	Sell	-54,200	Closed	-$3.54M	–	97
2017 Q1	$3.38M	Hold	54,200	–	–	1.13%	15
2016 Q4	$2.96M	Hold	54,200	–	–	1.01%	16
2016 Q3	$3.56M	Hold	54,200	–	–	3.04%	9
2016 Q2	$3.27M	Hold	54,200	–	–	1.07%	16
2016 Q1	$3.05M	Hold	54,200	–	–	1%	15
2015 Q4	$3.68M	Hold	54,200	–	–	1.22%	12
2015 Q3	$3.45M	Hold	54,200	–	–	1.16%	14
2015 Q2	$3.45M	Hold	54,200	–	–	1.1%	15
2015 Q1	$3.71M	Hold	54,200	–	–	1.1%	12
2014 Q4	$3.81M	Hold	54,200	–	–	1.08%	16
2014 Q3	$3.87M	Hold	54,200	–	–	1.14%	16
2014 Q2	$4.03M	Sell	54,200 -279	-0.5%	-$20.2K	1.21%	17
2014 Q1	$3.54M	Sell	54,479 -141	-0.3%	-$9.11K	1%	18
2013 Q4	$3.24M	Sell	54,620 -238	-0.4%	-$12.9K	0.91%	19
2013 Q3	$2.85M	Buy	54,858 +168	+0.3%	+$8.44K	0.95%	17
2013 Q2	$2.59M	Buy	+54,690	New	+$2.78M	0.98%	18

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fiduciary Trust International's AZN Position: Q2 2020 in Review

Fiduciary Trust International sold out of AstraZeneca (AZN) in Q2 2020, closing a stake of 54,200 shares — an estimated $4.84M sold.

Fiduciary Trust International first reported a position in AZN in Q2 2013 and held it in 27 quarters. The position peaked at $7.25M in Q3 2019. 668 funds tracked by Wall St. Rank hold AZN as of Q2 2020.

Fiduciary Trust International reported no remaining AstraZeneca position as of Q2 2020 after selling out during the quarter.
Fiduciary Trust International sold 54,200 AstraZeneca shares in Q2 2020, an estimated $4.84M.
Fiduciary Trust International first reported a position in AstraZeneca in Q2 2013 and held it in 27 quarters.
Fiduciary Trust International's AstraZeneca position peaked at $7.25M in Q3 2019.
668 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2020.

Based on Fiduciary Trust International's 13F filing for Q2 2020, filed 11 Aug 2020.